Average Co-Inventor Count = 8.24
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Abbvie Deutschland Gmbh and Co Kg (15 from 167 patents)
2. Abbvie Inc. (10 from 822 patents)
3. Abbott Gmbh & Co Kg (7 from 140 patents)
4. Abbott Laboratories Corporation (4 from 4,179 patents)
23 patents:
1. 10556907 - Fused heterocyclic compounds as S1P modulators
2. 10040852 - Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof
3. 9309200 - Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy
4. 9255146 - Neutralizing monoclonal antibodies against the Nogo-66 receptor (NgR) and uses thereof
5. 9242933 - Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)
6. 9238619 - Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
7. 9096619 - Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
8. 9067871 - Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy
9. 9045459 - Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
10. 8957089 - Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
11. 8877794 - Phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy
12. 8664214 - Small molecule potentiators of metabotropic glutamate receptors I
13. 8653100 - Tetrahydroisoquinolines, pharmaceutical compositions containing them, and their use in therapy
14. 8642587 - Heterocyclic compounds, pharmaceutical compositions containing them, and their use in therapy
15. 8563617 - Aminotetraline derivatives, pharmaceutical compositions containing them, and their use in therapy